{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:50:13Z","timestamp":1776747013712,"version":"3.51.2"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>MicroRNA-490-3p (miR-490-3p) plays a role in the pathogeneses of a\nvariety of cardiovascular diseases. Bioinformatic analysis showed that miR-490-3p was downregulated\nin the myocardial tissues of mice with myocardial infarction (MI). Nevertheless, the\nfunctions and mechanisms of miR-490-3p in MI remain unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study used an in-vitro model to investigate the role of miR-490-3p in MI. Human\ncardiac myocytes (HCMs) were cultured in a hypoxic environment. 3-(4,5)-Dimethylthiahiazo (-zy1)-\n3,5-di-phenytetrazoliumromide (MTT) assay and flow cytometry were used to detect cell\nviability and apoptosis. The expression levels of forkhead box O1 (FOXO1) and miR-490-3p were\ndetected by quantitative real-time PCR and Western blot. The levels of interleukin-6 (IL-6), tumor\nnecrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), lactate dehydrogenase (LDH), cardiac troponin I\n(cTnI), and creatine kinase MB (CK-MB) were detected by enzyme-linked immunosorbent assay\n(ELISA). The targeted relationship between miR-490-3p and FOXO1 3\u2019UTR was determined by a\ndual-luciferase reporter gene assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>miR-490-3p was significantly down-regulated in hypoxia-induced HCM cells, while\nFOXO1 was markedly up-regulated. miR-490-3p overexpression inhibited HCM cell inflammatory\nresponses and injury after hypoxia treatment. FOXO1 was validated to be a direct target of miR-\n490-3p, and its overexpression weakened the effects of miR-490-3p on cell viability, apoptosis, as\nwell as inflammatory responses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>miR-490-3p alleviates cardiomyocyte injury via targeting FOXO1 in MI.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866529666220819120736","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T06:37:05Z","timestamp":1660977425000},"page":"917-924","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["miR-490-3p Alleviates Cardiomyocyte Injury via Targeting FOXO1"],"prefix":"10.2174","volume":"29","author":[{"given":"Jin","family":"Jiang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Nanhua University, Hengyang 421001, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Nanhua University, Hengyang 421001, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Tang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Nanhua University, Hengyang 421001, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"Anderson J.L.","year":"2017","unstructured":"Anderson J.L.; Morrow D.A.; Acute myocardial infarction. N Engl J Med 2017,376(21),2053-2064","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"Reed G.W.","year":"2017","unstructured":"Reed G.W.; Rossi J.E.; Cannon C.P.; Acute myocardial infarction. Lancet 2017,389(10065),197-210","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cnc.2018.10.002","volume":"31","author":"Harrington D.H.","year":"2019","unstructured":"Harrington D.H.; Stueben F.; Lenahan C.M.; ST elevation myocardial infarction and non-ST elevation myocardial infarction. Crit Care Nurs Clin North Am 2019,31(1),49-64","journal-title":"Crit Care Nurs Clin North Am"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.55976\/cds.1202215611-16","volume":"1","author":"Somaschini A.","year":"2022","unstructured":"Somaschini A.; Astuti M.; Cordone S.; Ghione M.; Buscaglia E.; Cornara S.; Bellone P.; An unusual case of syncope due to silent coronary vasospasm. Cardiospace 2022,1(1),11-16","journal-title":"Cardiospace"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijcard.2016.11.198","volume":"228","author":"Mudaliar H.","year":"2017","unstructured":"Mudaliar H.; Rayner B.; Billah M.; Kapoor N.; Lay W.; Dona A.; Bhindi R.; Remote ischemic preconditioning attenuates EGR-1 expression following myocardial ischemia reperfusion injury through activation of the JAK-STAT pathway. Int J Cardiol 2017,228,729-741","journal-title":"Int J Cardiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","volume":"121","author":"Small E.M.","year":"2010","unstructured":"Small E.M.; Frost R.J.A.; Olson E.N.; MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010,121(8),1022-1032","journal-title":"Circulation"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"Bartel D.P.","year":"2004","unstructured":"Bartel D.P.; MicroRNAs. Cell 2004,116(2),281-297","journal-title":"Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/thno.29945","volume":"9","author":"Song Y.","year":"2019","unstructured":"Song Y.; Zhang C.; Zhang J.; Jiao Z.; Dong N.; Wang G.; Wang Z.; Wang L.; Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. Theranostics 2019,9(8),2346-2360","journal-title":"Theranostics"},{"key":"ref=9","first-page":"4932","volume":"23","author":"Zheng H.F.","year":"2019","unstructured":"Zheng H.F.; Sun J.; Zou Z.Y.; Zhang Y.; Hou G.Y.; MiRNA-488-3p suppresses acute myocardial infarction induced cardiomyocyte apoptosis via targeting ZNF791. Eur Rev Med Pharmacol Sci 2019,23(11),4932-4939","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=10","author":"Wu Y.","year":"2020","unstructured":"Wu Y.; Mao Q.; Liang X.; Targeting the MicroRNA-490-3p-ATG4B-autophagy axis relieves myocardial injury in ischemia reperfusion. J Cardiovasc Transl Res 2020","journal-title":"J Cardiovasc Transl Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"117445","DOI":"10.1016\/j.lfs.2020.117445","volume":"248","author":"Guo X.","year":"2020","unstructured":"Guo X.; Liu Y.; Zheng X.; Han Y.; Cheng J.; HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p\/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs. Life Sci 2020,248,117445","journal-title":"Life Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00380-019-01356-7","volume":"34","author":"Liu Y.","year":"2019","unstructured":"Liu Y.; Chen Y.; Tan L.; Zhao H.; Xiao N.; Linc00299\/miR-490-3p\/AURKA axis regulates cell growth and migration in atherosclerosis. Heart Vessels 2019,34(8),1370-1380","journal-title":"Heart Vessels"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphar.2019.00154","volume":"10","author":"Loi H.","year":"2019","unstructured":"Loi H.; Boal F.; Tronchere H.; Cinato M.; Kramar S.; Oleshchuk O.; Korda M.; Kunduzova O.; Metformin protects the heart against hypertrophic and apoptotic remodeling after myocardial infarction. Front Pharmacol 2019,10,154","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13073","DOI":"10.1074\/jbc.RA118.001880","volume":"293","author":"Spurthi K.M.","year":"2018","unstructured":"Spurthi K.M.; Sarikhani M.; Mishra S.; Desingu P.A.; Yadav S.; Rao S.; Maity S.; Tamta A.K.; Kumar S.; Majumdar S.; Jain A.; Raghuraman A.; Khan D.; Singh I.; Samuel R.J.; Ramachandra S.G.; Nandi D.; Sundaresan N.R.; Toll like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice. J Biol Chem 2018,293(34),13073-13089","journal-title":"J Biol Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/JCN.0b013e31828f0d25","volume":"29","author":"Anderson K.M.","year":"2014","unstructured":"Anderson K.M.; Discharge clinical characteristics and 60-day readmission in patients hospitalized with heart failure. J Cardiovasc Nurs 2014,29(3),232-241","journal-title":"J Cardiovasc Nurs"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e99495","DOI":"10.1371\/journal.pone.0099495","volume":"9","author":"Putko B.N.","year":"2014","unstructured":"Putko B.N.; Wang Z.; Lo J.; Anderson T.; Becher H.; Dyck J.R.B.; Kassiri Z.; Oudit G.Y.; Circulating levels of tumor necrosis factor alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: Evidence for a divergence in pathophysiology. PLoS One 2014,9(6),e99495","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"Gabisonia K.","year":"2019","unstructured":"Gabisonia K.; Prosdocimo G.; Aquaro G.D.; Carlucci L.; Zentilin L.; Secco I.; Ali H.; Braga L.; Gorgodze N.; Bernini F.; Burchielli S.; Collesi C.; Zandon\u00e0 L.; Sinagra G.; Piacenti M.; Zacchigna S.; Bussani R.; Recchia F.A.; Giacca M.; MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 2019,569(7756),418-422","journal-title":"Nature"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/bph.14155","volume":"175","author":"Huang S.","year":"2018","unstructured":"Huang S.; Frangogiannis N.G.; Anti inflammatory therapies in myocardial infarction: Failures, hopes and challenges. Br J Pharmacol 2018,175(9),1377-1400","journal-title":"Br J Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9986506","volume":"2021","author":"Xu Y.","year":"2021","unstructured":"Xu Y.; Guo W.; Zeng D.; Fang Y.; Wang R.; Guo D.; Qi B.; Xue Y.; Xue F.; Jin Z.; Li Y.; Zhang M.; Inhibiting miR-205 alleviates cardiac ischemia\/reperfusion injury by regulating oxidative stress, mitochondrial function, and apoptosis. Oxid Med Cell Longev 2021,2021,1-17","journal-title":"Oxid Med Cell Longev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","volume":"18","author":"Bejerano T.","year":"2018","unstructured":"Bejerano T.; Etzion S.; Elyagon S.; Etzion Y.; Cohen S.; Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett 2018,18(9),5885-5891","journal-title":"Nano Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/0963689719843806","volume":"28","author":"Xiao Y.","year":"2019","unstructured":"Xiao Y.; Zhao J.; Tuazon J.P.; Borlongan C.V.; Yu G.; MicroRNA-133a and myocardial infarction. Cell Transplant 2019,28(7),831-838","journal-title":"Cell Transplant"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41467-019-09530-1","volume":"10","author":"Gao F.","year":"2019","unstructured":"Gao F.; Kataoka M.; Liu N.; Liang T.; Huang Z.P.; Gu F.; Ding J.; Liu J.; Zhang F.; Ma Q.; Wang Y.; Zhang M.; Hu X.; Kyselovic J.; Hu X.; Pu W.T.; Wang J.; Chen J.; Wang D.Z.; Therapeutic role of miR-19a\/19b in cardiac regeneration and protection from myocardial infarction. Nat Commun 2019,10(1),1802","journal-title":"Nat Commun"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cvr\/cvs426","volume":"97","author":"Puthanveetil P.","year":"2013","unstructured":"Puthanveetil P.; Wan A.; Rodrigues B.; FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovasc Res 2013,97(3),393-403","journal-title":"Cardiovasc Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1002\/ehf2.13065","volume":"7","author":"Yu W.","year":"2020","unstructured":"Yu W.; Chen C.; Cheng J.; The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy. ESC Heart Fail 2020,7(6),3497-3504","journal-title":"ESC Heart Fail"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-physiol-021909-135931","volume":"72","author":"Ronnebaum S.M.","year":"2010","unstructured":"Ronnebaum S.M.; Patterson C.; The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 2010,72(1),81-94","journal-title":"Annu Rev Physiol"},{"key":"ref=26","first-page":"5941","volume":"23","author":"Qin X.D.","year":"2019","unstructured":"Qin X.D.; Liu L.; Loss of microRNA-27a induces cardiac dysfunction through activating FoxO1. Eur Rev Med Pharmacol Sci 2019,23(13),5941-5948","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.3892\/etm.2019.7908","volume":"18","author":"Qiu Z.","year":"2019","unstructured":"Qiu Z.; Wang L.; Mao H.; Xu F.; Sun B.; Lian X.; Wang J.; Kong F.; Wang L.; Chen Y.; MiR 370 inhibits the oxidative stress and apoptosis of cardiac myocytes induced by hydrogen peroxide by targeting FOXO1. Exp Ther Med 2019,18(4),3025-3031","journal-title":"Exp Ther Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.yjmcc.2014.06.006","volume":"74","author":"Cai B.","year":"2014","unstructured":"Cai B.; Wang N.; Mao W.; You T.; Lu Y.; Li X.; Ye B.; Li F.; Xu H.; Deletion of FoxO1 leads to shortening of QRS by increasing Na+ channel activity through enhanced expression of both cardiac NaV1.5 and \u03b23 subunit. J Mol Cell Cardiol 2014,74,297-306","journal-title":"J Mol Cell Cardiol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866529666220819120736","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207715\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866529666220819120736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:52:32Z","timestamp":1692895952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207715\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866529666220819120736","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}